Showing results (191-200 of 214) with videos related to
Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2013
Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapiesMatthew J Brauer, Guanglei Zhuang, Maike Schmidt, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Quantifying antivascular effects of monoclonal antibodies to vascular endothelial growth factor: insights from imagingJames P B O'Connor, Richard A D Carano, Andrew R Clamp, et al.Elife|June 25, 2013
Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1Ling Luo, Hironori Uehara, Xiaohui Zhang, et al.Plos One|September 15, 2010
Molecular biomarker analyses using circulating tumor cellsElizabeth A Punnoose, Siminder K Atwal, Jill M Spoerke, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2011
Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancerAdrian M Jubb, Kathy D Miller, Hope S Rugo, et al.Nature|October 20, 2006
Corneal avascularity is due to soluble VEGF receptor-1Balamurali K Ambati, Miho Nozaki, Nirbhai Singh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2018
Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer ImmunotherapyF Stephen Hodi, Marcus Ballinger, Benjamin Lyons, et al.Lancet (London, England)|March 14, 2016
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trialLouis Fehrenbacher, Alexander Spira, Marcus Ballinger, et al.Nature|November 28, 2014
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancerThomas Powles, Joseph Paul Eder, Gregg D Fine, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of AtezolizumabOmid Hamid, Luciana Molinero, Christopher R Bolen, et al.Pageof 22